The prostate cancer news for Thursday, July 30

News items today are focused on information about:

a new way of approaching treatment of hormone-refractory disease
the initial clinical trials of a new drug candidate in hormone-refractory patients
the association between hospital and surgeon volume and patient outcomes after radical prostatectomy.

What’s the prostate cancer news today? Wednesday, July 29th

Actually it’s very quiet today. Nothing disease-specific at all on the wires so far. Probably there was so much news yesterday (click here and here). So we thought we’d update you on what The “New” Prostate Cancer InfoLink has been up to.

Prostate cancer news update, PART B: Tuesday, July 28

Here is Part B of your daily prostate cancer news update. Unless someone announces a cure for prostate cancer we will probably hold any further news until tomorrow!

Prostate cancer news update, PART A: Tuesday, July 28

There’s a lot of news this morning, so we are breaking it up into two sections (Parts A and B) to make it easier to read.

CyberKnife “robotic radiosurgery” for localized prostate cancer …

… Are we getting things out of proportion?
The CyberKnife® system  was initially developed as a method to treat tumors in places like the brain that were inaccessible to physical surgery, and was originally approved by the FDA in 1992. Now it is being touted as “the next thing” in “radiosurgery” for prostate cancer.

Your prostate cancer news “fix” for Monday, July 27th

In today’s prostate cancer news:

More on the effects of hormone therapy on cognitive function and
The application to market satraplatin has been withdraw in Europe

Abiraterone update: a patient interviews de Bono

Here’s a link to an excellent article on the “real” abiraterone story, written by journalist Robert Sandall, who has advanced prostate cancer himself. He has spoken to researcher Johann de Bono directly, and quotes him as follows:
Some parts of the press have hyped this drug way beyond what I said about it. … This is not [...]

Appointment of Scientific Advisory Board

The “New” Prostate Cancer InfoLink is pleased to announce the appointment of a Scientific Advisory Board under the chairmanship of Prof. Judd Moul, MD of the Duke Prostate Center. The media announcement can be seen in full in the “Newsroom.”

Weekend prostate cancer news update: Saturday, July 26

Articles summarized in this weekend news update include information about:

The value of endorectal MRI imaging in staging patients with respect to whether they have cancer confined to the prostate or extracapsular disease
Patterns of disease recurrence after salvage radical prostatectomy for patients with radiation-recurrent disease
The potential of PSA kinetics to improve prediction of likelihood for survival in men [...]

New prostate cancer patient/partner support program

Have you just been diagnosed with prostate cancer? Or do you know someone who has?
If you have just been diagnosed with prostate cancer, you may be trying to work out how you and your spouse or partner are going to deal with this experience. The University of Arizona College of Nursing has initiated a new program called [...]